Table 1 Baseline clinical and biochemical characteristics in the MS group and non-MS group

Age (years), mean ± SD

61.5 ± 9.29

61.6 ± 8.70

0.787

Male, n (%)

240 (49.2)

323 (49.8)

0.857

BMI (kg/cm²), mean ± SD

26.6 ± 3.43

25.2 ± 3.31

0.001

Waist circumference (cm), mean ± SD

93.7 ± 6.80

88.3 ± 6.34

<0.001

Hypertension, n (%)

307 (62.9)

369 (56.9)

0.043

Diabetes, n (%)

306 (57.8)

425 (34.4)

<0.001

Hyperlipidemia, n (%)

276 (56.6)

261 (40.3)

<0.001

FBG (mmol/L), mean ± SD

6.5 ± 3.48

6.4 ± 3.66

0.046

LDL (mmol/l), mean ± SD

3.5 ± 0.76

3.2 ± 0.87

<0.001

TG (mmol/l), mean ± SD

1.8 ± 1.43

1.5 ± 0.92

0.001

HDL (mmol/l), mean ± SD

0.9 ± 0.69

1.0 ± 0.69

0.165

hsCRP (mg/l), mean ± SD

8.0 ± 2.72

7.1 ± 3.15

<0.001

 Hypertension, n (%)

209 (42.9)

190 (44.8)

0.518

 Diabetes, n (%)

187 (38.5)

217 (33.5)

0.079

 Hyperlipidemia, n (%)

127 (26.1)

191 (29.5)

0.201

 Aspirin, n (%)

223 (45.7)

268 (41.4)

0.147

 Statins, n (%)

116 (23.8)

127 (19.6)

0.093

 Presence of high-risk plaque, n (%)

326 (66.8)

378 (58.3)

0.004

 MACEs, n (%)

144 (27.5)

76 (11.7)

<0.001